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ight junctions are well-developed between adjacent
endothelial cells of blood vessels in the central nervous
system, and play a central role in establishing the
blood-brain barrier (BBB). Claudin-5 is a major cell adhesion
molecule of tight junctions in brain endothelial cells. To
examine its possible involvement in the BBB, claudin-5–
deﬁcient mice were generated. In the brains of these
mice, the development and morphology of blood vessels
were not altered, showing no bleeding or edema. How-
T
 
ever, tracer experiments and magnetic resonance imaging
revealed that in these mice, the BBB against small mole-
cules (
 
 
 
800 D), but not larger molecules, was selectively
affected. This unexpected ﬁnding (i.e., the size-selective
loosening of the BBB) not only provides new insight into
the basic molecular physiology of BBB but also opens a
new way to deliver potential drugs across the BBB into the
central nervous system.
 
Introduction
 
The existence of the blood-brain barrier (BBB)* was first
described by Ehrlich (1885) more than 100 yr ago. He
found that dyes injected into veins stained all the organs
but the brain. Since then, the BBB has been thought to
protect the brain from various harmful materials circulating
in the blood (for reviews see Pardridge, 1998; Rubin and
Staddon, 1999). On the other hand, the BBB prevents
many potential drugs from entering the central nervous
system (CNS). Therefore, many researchers have tried to
loosen the BBB for therapeutic purposes in various CNS
disorders (for reviews see Miller, 2002; Pardridge, 2002),
but limited information on the molecular basis for BBB
has hampered these trials.
To establish BBB, well-developed tight junctions (TJs)
between adjacent endothelial cells are indispensable, in addition
to various transporters in their plasma membranes (Reese and
Karnovsky, 1967; for reviews see Pardridge, 1998; Rubin and
Staddon, 1999; Edwards, 2001; Wolburg and Lippoldt,
2002). TJs are one mode of cell–cell adhesion, and play a
central role in sealing the intercellular space in epithelial and
endothelial cellular sheets (e.g., barrier function; for reviews
see Schneeberger and Lynch, 1992; Anderson and van Itallie,
1995; Tsukita et al., 2001). On ultrathin section electron
microscopy, TJs appear as a zone where plasma membranes
of neighboring cells focally make complete contact (Farquhar
and Palade, 1965). On freeze-fracture electron microscopy,
TJs are visualized as a continuous, anastomosing network of
intramembranous particle strands (TJ strands or fibrils) and
complementary grooves (Staehelin, 1974). These observa-
tions led to our current understanding of the three-dimensional
structure of TJs: at TJs, within the lipid bilayer of each
membrane, some specific integral membrane proteins aggregate
linearly to constitute “TJ strands.” Individual TJ strands then
laterally and tightly associate with those in the apposing
membrane of adjacent cells to form paired strands, where the
intercellular distance becomes almost zero (so-called “kissing
points” of TJs; for review see Tsukita et al., 2001).
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Several peripheral membrane proteins such as ZO-1 were
reported to concentrate at the cytoplasmic surface of TJs (for
review see Schneeberger and Lynch, 1992; Anderson and
van Itallie, 1995; Balda and Matter, 1998; Tsukita et al.,
1999, 2001). Until recently, information on TJ adhesion
molecules has been lacking, but now three distinct types of
integral membrane proteins are known to be localized at
TJs: occludin (Furuse et al., 1993), junctional adhesion mol-
ecule (JAM) (Martin-Padura et al., 1998), and claudin (Cld;
Furuse et al., 1998a). Occludin, an 
 
 
 
65-kD integral mem-
brane protein with four transmembrane domains, was iden-
tified as the first component of TJ strands (Furuse et al.,
1993). However, several studies including gene knockout
analyses revealed that TJ strands can be formed without oc-
cludin (Balda et al., 1996; Saitou et al., 1998). JAM with a
single transmembrane domain was recently shown to associ-
ate laterally with TJ strands, but not to constitute the
strands per se (Itoh et al., 2001). In contrast, Cld is now be-
lieved to be a major constituent of TJ strands (for review see
Tsukita et al., 2001). Clds with molecular masses of 
 
 
 
23
kD comprise a multigene family consisting of 
 
 
 
20 members
(Morita et al., 1999a; Tsukita et al., 2001). Clds also bear
four transmembrane domains, but do not show any se-
quence similarity to occludin. Interestingly, when each Cld
species was overexpressed in mouse L fibroblasts lacking en-
dogenous Clds, exogenously expressed Cld molecules were
polymerized within the plasma membrane to reconstitute
“paired” TJ strands at cell–cell contact regions (Furuse et al.,
1998b). Furthermore, through further detailed transfection
experiments as well as immunolabeling studies, it is now
widely accepted that heterogeneous Cld species constitute
the backbone of TJ strands in situ; i.e., TJ strands are copoly-
mers of heterogeneous Cld species (and also occludin; Furuse
et al., 1999; Tsukita et al., 2001).
Recently, Cld-5 was found specifically in endothelial cells,
in large amounts especially in the brain endothelial cells
(Morita et al., 1999b), leading to the idea that Cld-5 may be
directly involved in the establishment of the BBB. In this pa-
Figure 1. Generation of Cld-5–deficient mice. 
(a) Restriction maps of the wild-type allele, the 
targeting vector, and the targeted allele of the mouse 
Cld-5 gene. Only one exon covers the whole open 
reading frame of Cld-5. The targeting vector 
contained the pgk neo cassette in its middle portion 
to delete the exon in the targeted allele. The positions 
of the 5  and 3  probes for Southern blotting are 
indicated as bars. E, EcoRI; Sa, SacI; K, KpnI; N, NcoI; 
and S, Sse8387I. (b) Genotype analyses by Southern 
blotting of Eco RI-digested genomic DNA from wild-
type ( / ), heterozygous ( / ), and homozygous 
( / ) mice for the mutant Cld-5 gene allele. 
Southern blotting with 5  and 3  probes yielded an 
8.4-kb band from the wild-type allele, and a 4.7- and 
3.7-kb band from the targeted allele, respectively. 
(c) Loss of Cld-5 mRNA in the brain of Cld-5
 /  mice 
examined by RT-PCR. As a control, the hypoxanthine 
phosphoribosyl transferase gene was equally 
amplified in all samples. (d) Newborn Cld-5
 /  and 
Cld-5
 /  mice. Homozygous Cld-5–deficient mice 
were born in the expected Mendelian ratios, and 
looked normal macroscopically. However, their 
movements gradually ceased, and they all died 
within 10 h of birth.
Figure 2. Vasculogenesis and the brain histology of Cld5
    mice. 
(a and a ) Whole-mount immunostaining. Mouse 9.5-d wild-type 
and Cld5
 /  embryos were labeled with anti–PECAM-1 mAb. The 
characteristic treelike and ladderlike staining patterns of blood 
vessels in the head and vertebrate portions were observed both in 
wild-type and Cld5
 /  embryos. (b, b , c, and c ) Hematoxylin-eosin–
stained paraffin sections (b and b ) and anti–PECAM-1–stained frozen 
sections (c and c ) of the wild-type and Cld5
 /  brains of 18.5-d 
embryos. No difference was detected. Bars: (a and a ) 300  m; 
(b and b ) 100  m; (c and c ) 40  m.T
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per, to evaluate this idea, we generated Cld-5–deficient mice
by homologous recombination, and found that in these mice
the BBB was loosened in a size-selective manner. We believe
that this work marks the first step in developing a new TJ-
based method of drug delivery to the CNS.
 
Results
 
Generation of Cld-5–deficient mice
 
We produced mice unable to express Cld-5. Nucleotide se-
quencing as well as restriction mapping identified only one
Figure 3. Ultrastructure of brain blood vessels in Cld5
 /  mice. In the Cld5
 /  brains of 18.5-d embryo, ultrathin-section electron microscopy 
revealed no overt morphological abnormalities in the blood vessels. TJs were observed between adjacent endothelial cells, and at higher mag-
nification, so-called kissing points of TJs were clearly visualized (arrowheads). Bars: (left) 4  m; (middle) 0.2  m; (right) 50 nm.
Figure 4. Cld-12 in brain blood vessels. 
(a) Specificity of newly generated anti–Cld-12 
pAb. Immunoblotting of total lysates of 
Escherichia coli expressing GST fusion proteins 
with cytoplasmic domains of Cld-1–16 confirmed 
its specificity. CBB, Coomassie brilliant blue 
staining; anti–Cld-12 pAb, immunoblotting 
with anti–Cld-12 pAb. (b) Frozen sections of 
the wild-type and Cld5
 /  brains of 18.5-d 
embryo were double stained with anti–ZO-1 
mAb and anti–Cld-5 pAb or anti–Cld-12 pAb. 
Cld-5 was completely undetectable from the 
Cld5
 /  brain. Cld-12 was concentrated at 
ZO-1–positive TJs not only in the wild-type but 
also in the Cld5
 /  brain endothelial cells. 
These Cld-12 signals were abolished when the 
anti–Cld-12 pAb was preincubated with the 
GST-Cld-12 fusion protein. There appeared to 
be no significant difference in the intensity of 
Cld-12 signal between the wild-type and Cld5
 /  
brain endothelial cells. The concentration of 
occludin at TJs of endothelial cells was not 
affected in the Cld5
 /  brain (unpublished data). 
Bar, 20  m.T
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exon that covers the whole open reading frame of Cld-5.
We constructed a targeting vector, which was designed to
disrupt the 
 
Cld-5
 
 gene by replacing its exon with the neo-
mycin resistance gene (Fig. 1 a). Two distinct lines of mice
were generated from distinct embryonic stem (ES) cell
clones in which the 
 
Cld-5
 
 gene was disrupted by homolo-
gous recombination. Southern blotting confirmed the dis-
ruption of the 
 
Cld-5
 
 gene in heterozygous as well as ho-
mozygous mutant mice (Fig. 1 b), and RT-PCR detected
no Cld-5 mRNA from the brains of homozygous mutant
mice (
 
Cld5
 
 
 
/
 
 
 
 
 
mice; Fig. 1 c). 
 
Cld5
 
 
 
/
 
 
 
 
 
mice were born in
the expected Mendelian ratios, and looked normal macro-
scopically (Fig. 1 d). However, their movements gradually
ceased, and they all died within 10 h of birth. Because both
lines of mice showed the same phenotypes, we will mainly
present data obtained from one line.
 
Morphology of brain blood vessels 
in Cld-5–deficient mice
 
We examined the brain blood vessels morphologically in
 
Cld5
 
 
 
/
 
 
 
 
 
mice. As shown in Fig. 2 (a and a
 
 
 
), whole-mount
immunostaining of 9.5-d embryos for PECAM-1, an en-
dothelial cell marker, detected no significant abnormality in
the vasculogenesis in 
 
Cld5
 
 
 
/
 
 
 
 
 
mice. Furthermore, in both
hematoxylin-eosin and anti–PECAM-1 mAb stainings of
the brain sections of 18.5-d embryos, no difference was dis-
cerned between wild-type and 
 
Cld5
 
 
 
/
 
 
 
 
 
mice (Fig. 2, b, b
 
 
 
,
c, and c
 
 
 
). No signs of bleeding or edema were detected in
the 
 
Cld5
 
 
 
/
 
 
 
 
 
brain. Consistently, there was no difference in
the brain tissue water content between newborn wild-type
(85.6 
 
 
 
 0.38%, 
 
n 
 
  
 
11) and 
 
Cld5
 
 
 
/
 
 
 
 mice (85.4 
 
 
0.30%, n   12).
At the electron microscopic level, the blood vessels of the
brain of newborn Cld5
 /  mice did not exhibit overt mor-
phological abnormalities (Fig. 3). Close inspection re-
vealed that, even in Cld5
 /  mice, TJs with a normal ap-
pearance occurred at the endothelial cell–cell contact
Figure 5. Impairment of the BBB in the Cld5
 /  brains of 18.5-d 
embryos. Primary amine-reactive biotinylation reagent (443 D) 
was perfused from the heart of resuscitated embryos. After a 5-min 
incubation, sagittal frozen sections from the whole body (a and a ) 
or the brain (b, b , c, and c ) were incubated with HRP-conjugated 
streptavidin to localize the biotinylation reagent by peroxidase 
activity. At a low magnification in the wild-type mouse (a), the 
reagent was completely excluded from the brain (arrow) and the 
spinal cord (arrowhead); in sharp contrast, in the Cld5
 /  mouse 
(a ), the CNS showed intense peroxidase activity. At a higher 
magnification, in the Cld5
 /  (b  and c ) but not in the wild-type 
brain (b and c), the reagent infiltrated abundantly into the parenchyma. 
Bars: (a and a ) 2 mm; (b and b ) 40  m; (c and c ) 10  m.
Figure 6. Time course of the biotinylation reagent leakage from 
the blood vessels in the Cld5
 /  brains. Primary amine-reactive 
biotinylation reagent (443 D) was perfused from the heart of 
resuscitated embryos. After a 1, 3, 5, or 10-min incubation, frozen 
sections from the brain were incubated with rhodamine-conjugated 
streptavidin to visualize the distribution of the injected biotinylation 
reagent. Bar, 50  m.T
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regions, showing the so-called kissing points of TJs. Con-
sidering that Cld-5 disappeared from the endothelial cells
(Fig. 4), this finding suggested that in endothelial cells of
the wild-type brain, TJ strands were not only composed of
Cld-5 but also other Cld species. We researched for such
endothelial cell-specific Cld among Cld-1–16 using avail-
able and newly generated antibodies, and found that, in
addition to Cld-5, Cld-12 was expressed in large amounts
and colocalized with ZO-1 in the wild-type brain endothe-
lial cells and also in the Cld5
 /   brain endothelial cells
(Fig. 4). Thus, we concluded that in the Cld5
 /  brain,
Cld-5 was simply removed from the TJs of endothelial
cells, leaving TJs consisting of at least Cld-12.
Size-selective loosening of the BBB 
in Cld-5–deficient mice
The important question is whether the barrier function of TJs
(i.e., the BBB) is affected in the Cld5
 /  brain endothelial
cells. To evaluate the BBB in Cld5
 /  mice, we performed
tracer experiments: Cld5
 /   intercross littermates were ob-
tained by Caesarian section at embryonic day 18.5, resusci-
tated, and perfused with tracers from the left cardiac ventricle.
These littermates were later genotyped. First, we used a pri-
mary amine-reactive biotinylation reagent (443 D), which co-
valently cross-links to accessible proteins, as a tracer. This
tracer has been successfully used so far to evaluate the perme-
ability of TJs of epithelial cells (Chen et al., 1997; Furuse et
al., 2002). 5 min after perfusion, the localization of the bio-
tinylation reagent was examined on sagittal whole body sections
using HRP-conjugated streptavidin (Fig. 5, a and a ). In wild-
type embryos, the reagent was specifically excluded from the
CNS. This was indeed confirmation of Ehrlich’s work, which
first described the BBB (Ehrlich, 1885). In contrast, in the
Cld5
 /  mice, the brain and the spinal cord showed strong
and diffused HRP activity. At a higher magnification in the
wild-type brain, the biotinylation reagent was retained in the
blood vessels, whereas in the Cld5
 /  brain, this reagent was
distributed diffusely throughout the brain parenchyma with
some concentration in blood vessels (Fig. 5, b , b , c, and c ).
Fig. 6 represents the time course of the leakage of the biotin-
ylation reagent from blood vessels in the Cld5
 /  brain. This
reagent appeared to have already passed through the BBB 1
Figure 7. Size-selective loosening of the BBB 
in Cld5
 /  mice. (a) Paraffin sections of the brain 
were de-paraffined and stained with rabbit 
antialbumin pAb, followed by incubation with 
HRP-conjugated anti–rabbit IgG pAb. Bound pAb 
was visualized by peroxidase activity. No leakage 
of endogenous serum albumin was observed in the 
Cld5
 /  brain. Bar, 40  m. (b) Microperoxidase 
( 1.9 kD) was injected into the heart of resuscitated 
embryos, and after a 5-min incubation, the brain 
was fixed. The localization of microperoxidase 
was visualized by peroxidase activity in frozen 
sections. No leakage of microperoxidase was 
observed in the Cld5
 /  brain. Bar, 40  m. (c) A 
mixture of tetramethylrhodamine-conjugated dextran 
( 10 kD) and a dye for nuclear staining (Hoechst 
stain H33258; 562 D) was perfused, and frozen 
sections were observed under a fluorescence microscope. In the wild-type brain, neither dextran (red) nor Hoechst dye (blue) extravasated, 
whereas in the Cld5
 /  brain, Hoechst dye, but not dextran, extravasated to stain the nuclei of surrounding neurons/glial cells. Bar, 30  m.
min after perfusion. These findings clearly demonstrated that
the BBB was severely affected in Cld5
 /  mice.
If serum proteins extravasate freely in the brain, vasogenic
edema should be induced. However, as mentioned in Fig. 2 b,
there was no sign of the edema in the Cld5
 /  brain. We
checked for the possible leakage of serum albumin ( 68 kD)
from blood vessels in the Cld5
 /  brain (Liu, 1988; Vinores et
al., 1989; Fig. 7 a). Interestingly, immunostaining with antial-
bumin polyclonal antibody (pAb) showed no leakage of se-
rum albumin, which was completely retained in the blood
vessels. Furthermore, we performed tracer experiments using
microperoxidase ( 1.9 kD) as a tracer (Knothe Tate et al.,
1998). As shown in Fig. 7 b, no leakage from the brain blood
vessels was detected in the Cld5
 /  brain. These findings sug-
gested that, in the Cld5
 /  brain, the BBB (i.e., the TJ barrier
of endothelial cells) was loosened in a size-selective manner. If
so, the absence of vasogenic edema in the Cld5
 /  brain can
be explained. In Fig. 7 c, to confirm this speculation, we per-
fused a mixture of tetramethylrhodamine-conjugated dex-
tran ( 10 kD) and a fluorescence dye for nuclear staining
(Hoechst stain H 33258; 562 D) through the heart (Chang-
Ling et al., 1992; Hu et al., 2000). After a 5-min incubation,
in the wild-type brain, both dextran and H33258 were re-
tained in blood vessels. H33258 stained only the nuclei of en-
dothelial cells. Interestingly, in the Cld5
 /  brain, nuclei of not
only endothelial cells but also surrounding neurons/glial cells
were intensively stained by H33258, whereas dextran was de-
tected only within blood vessels.
Magnetic resonance imaging (MRI) analyses of the BBB 
impairment in Cld-5–deficient mice
Finally, we quantitatively examined impairment of the
BBB in live Cld5
 /  mice using MRI with the longitudi-
nal (T1) relaxation reagent gadolinium–diethylene triamine-
N,N,N ,N ,N -pentaacetic acid (Gd-DTPA; 742 D; Abbott
et al., 1999; Caravan et al., 1999; Seo et al., 2002). We in-
jected various dosages of Gd-DTPA into the heart of resusci-
tated 18.5-d embryos. The sagittal T1-weighted images of the
wild-type brain clearly exhibited the existence of the BBB;
the signal from most organs except the CNS was significantly
enhanced by Gd-DTPA perfusion. In contrast, in the Cld5
 / 
mice, the signals from all areas of the CNS were markedlyT
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enhanced, and the degree of enhancement depends on the
dosage of injected Gd-DTPA (Fig. 8 a). In Fig. 8 b, we exam-
ined the relationship between the averaged T1 relaxation rate
of water in the brain and the dosage of injected Gd-DTPA
(Seo et al., 2002). On the assumption of a simple two-com-
partment exchange model (Fabry and Eisenstadt, 1978;
Schwarzbauer et al., 1997), this relationship allowed us to es-
timate that the Gd-DTPA–accessible space per unit volume
of the wild-type and Cld5
 /  brain was 1.2   0.8% and
14.7    4.2% (regression coefficient   SD), respectively.
This finding indicated that in the wild-type brain, Gd-DTPA
was retained only within the blood vessels ( 1% of the total
volume), and that in the Cld5
 /  brain, it extravasated and
distributed diffusely in the extracellular space of neurons/glia
cells ( 15% of the total volume). Therefore, it is safe to say
that, quantitatively, the BBB against Gd-DTPA was severely
affected in the Cld5
 /  brain.
Discussion
Blood vessels are lined with a single layer of endothelial cel-
lular sheets. These cellular sheets function as barriers to
maintain the internal environment of blood vessels, but var-
ious materials must be selectively transported across these
sheets. There are two pathways through which materials
cross endothelial cellular sheets: the transcellular pathway
including transcytosis through the cell and the paracellular
pathway through TJs (for reviews see Spring, 1998; Tsukita
et al., 2001). In the blood vessels in the CNS, the endothe-
lial cellular sheets function as very tight barriers, constitut-
ing the so-called BBB (for reviews see Pardridge, 1998; Ru-
bin and Staddon, 1999). For the establishment of the BBB,
first, the transport of materials through transcellular path-
ways should be suppressed so completely that specialized
transport systems are required in the plasma membranes of
endothelial cells for the uptake of even small molecules such
as glucose and amino acids by the CNS (for reviews see Par-
dridge, 1998, 2002; Edwards, 2001; Miller, 2002). Fur-
thermore, when some materials are leaked into the paren-
chyma of the CNS, the multi-drug resistance transporter
mdr1a (P-glycoprotein 1), which is concentrated in the en-
dothelial cell plasma membranes, redistributes them out of
the brain parenchyma into endothelial cells and, hence,
back to the blood (Cordon-Cardo et al., 1989; Schinkel et
al., 1994; Edwards, 2001). Second, the paracellular route
also should be tightly sealed. TJs are markedly developed
compared with those in endothelial cells in nonneuronal
tissues (Reese and Karnovsky, 1967; Wolburg and Lip-
poldt, 2002). Taking these cellular bases for the BBB into
consideration, TJs have been considered attractive targets
for transient breakdown of the BBB in therapies for various
CNS disorders.
We found that TJs in the brain blood vessels are primarily
composed of at least two distinct species of Clds: Cld-5 and
-12. Anti–Cld-1 pAb also stained the blood vessels in the
wild-type brain as previously reported (Liebner et al., 2000),
but this staining was still positive in the Cld-1–deficient
mice (unpublished data). We examined the roles of Cld-5 in
the BBB by generating Cld-5–deficient mice. In the Cld5
 / 
brain, Cld-5 was simply removed from the TJs of endothe-
lial cells, leaving morphologically normal blood vessels as
well as the Cld-12–based TJs. However, in terms of the bar-
rier function, these endothelial TJs showed a peculiar abnor-
mality. Tracer experiments and MRI revealed that in these
mice, the BBB is severely affected against small molecules
(less than  800 D), but not larger molecules. In other
words, the Cld-12–based TJs in Cld5
 /  brain blood vessels
would function as a molecular sieve. They allow only small
molecules (less than  800 D) to pass across TJs. Of course,
Figure 8. MRI of 18.5-d embryos. (a) Mid-sagittal T1-weighted 
images of the wild-type and Cld5
 /  brain after the transcardial 
injection of Gd-DTPA (0.0, 0.5, and 1.0 mmol/kg body wt). Due to 
shortening of the T1 relaxation time, the Gd-DTPA–accessible area 
was represented as a high signal intensity. In the wild-type mice, 
Gd-DTPA did not enter the extravascular space in the CNS, so the 
brain parenchyma (top middle, arrow) maintained a constant image 
intensity even at a high dose of Gd-DTPA. By contrast, in the Cld5
 /  
brain, the image intensity in all areas of the CNS (bottom middle, 
arrow), including the spinal cord, was enhanced by Gd-DTPA, 
and the degree of enhancement depends on the dosage of injected 
Gd-DTPA. (b) The relationship between the relaxation rate of water 
(1/T1) in the brain and the dosage of injected Gd-DTPA. As 1/T1 
of the brain, 1/T1 values of the five ROIs (156   156   750 mm) 
including the cortex, thalamus, hypothalamus, cerebellum, and 
pons were averaged. The bold and dotted lines are the results of 
fitting and 95% confidence limits, respectively. As explained in 
the text, on the assumption of a simple two-compartment exchange 
model (Fabry and Eisenstadt, 1978; Schwarzbauer et al., 1997), 
this relationship allowed us to estimate quantitatively the Gd-DTPA–
accessible space per unit volume of the brain.T
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this molecular mass cut-off ( 800 D) is tentative because
the tracers used in this work have all a different chemical
structure and differ in charge and hydrophilicity.
The size-selective loosening of TJs in Cld5
 /  brain blood
vessels is consistent with the previous data on epithelial TJs.
The TJs of MDCK I epithelial cells were primarily com-
posed of Cld-1 and -4, and when Cld-4 was removed from
these TJs using a Cld-4–binding peptide, the continuous
Cld-1–based TJs still persisted, which leaked 4 kD/10 kD
dextran, but not 40 kD dextran (Sonoda et al., 1999). Fur-
thermore, we recently found that the TJs in the epidermis
were also composed of Cld-1 and -4. In Cld-1–deficient
mice, there still remained the continuous Cld-4–based TJs
in the granular layer of the epidermis, and the layered orga-
nization of keratinocytes in the epidermis was not affected
(Furuse et al., 2002). However, interestingly, the epidermal
barrier against water was severely affected, resulting in the
dehydration of newborn mice. In general, it is, thus, safe to
say that, when TJs are composed of more than two distinct
species of Clds, the removal of one Cld species changes the
barrier function of TJs markedly while keeping their contin-
uous structural integrity.
Therefore, in the Cld5
 /  brain, the existence of the Cld-
12–based TJs would keep the structural integrity (and the
polarity) of endothelial cells, showing no bleeding. Further-
more, the size selectivity of the Cld-12–based TJs did not
allow most serum proteins to extravasate, resulting in no va-
sogenic edema. From the viewpoint of the drug delivery,
the lack of bleeding and edema is very important and ad-
vantageous. Therefore, Cld-5 can be regarded as a potential
target for developing a new drug delivery method for CNS
disorders. Of course, it is possible that impairment of the
BBB, even if temporary or in a size-selective manner, would
be harmful to CNS activity to some extent. Indeed, Cld5
 / 
mice died within 10 h of birth. Cld-5 is expressed in large
amounts in all segments of the blood vessels in the brain,
but it is also detected in some segments of the blood vessels
of nonneural tissues such as the lung and kidney (Morita et
al., 1999b). Various tissues were examined histologically in
hematoxylin-eosin–stained sections of Cld5
 /  mice, but
no significant abnormalities were detected (unpublished
data). Therefore, at this moment it is not easy to discuss a
causal sequence between BBB impairment and death in
Cld5
 /  mice. To answer this question, as well as to better
understand the basic physiology of the BBB, we should
generate mice in which Cld-5 gene can be conditionally
knocked out in the endothelial cells of the brain blood ves-
sels in adult mice.
Materials and methods
Antibodies
Rat anti–PECAM-1 mAb (BD Biosciences), rat anti–mouse ZO-1 mAb
(CHEMICON International, Inc.), rabbit anti–Cld-5 pAb (Zymed Laborato-
ries), and rabbit anti–mouse albumin pAb (Inter-Cell Technology, Inc.)
were purchased. Anti–Cld-12 pAb was raised as follows. A polypeptide
corresponding to the COOH-terminal cytoplasmic domain of mouse Cld-
12 (a cysteine residue was added at its NH2 terminus) was synthesized and
coupled via the cysteine residue to keyhole limpet hemocyanin. This pep-
tide was injected into rabbits as an antigen. Rabbit antisera were affinity-
purified on nitrocellulose membranes with GST fusion proteins with Cld-
12 before use.
Generation of Cld5
 /  mice
Two overlapping clones encoding mouse Cld-5 were obtained by screen-
ing a 129/Sv genomic library. Using them, the targeting vector was con-
structed as shown in Fig. 1 a. The diphthelia toxin A expression cassette
(MC1pDT-A) was placed outside the 3  arm of homology for negative se-
lection. As shown in Fig. 1 a, only one exon covered the whole open read-
ing frame of Cld-5. Thus, this targeting vector was designed to delete this
exon by replacing with the pgk-neo cassette. J1 ES cells were electropo-
rated with the targeting vector and selected for  9 d in the presence of
G418. The G418-resistant colonies were removed and screened by South-
ern blotting with the 5  and 3  external probes (Fig. 1 a). When digested
with EcoRI, correctly targeted ES clones were identified by an additional
4.7-kbp band together with the 8.4-kbp band of the wild-type allele with
the 5  probe, and by an additional 3.7-kbp band together with the 8.4-kb
band of the wild-type allele with the 3  probe. The targeted ES cells ob-
tained were injected into C57BL/6 blastocysts, which were, in turn, trans-
ferred into BALB/c foster mothers to obtain chimeric mice. Male chimeras
were mated with C57BL/6 females, and agouti offsprings were genotyped
to confirm the germline transmission of the targeted allele. The littermates
were genotyped by Southern blotting. Next, heterozygous mice were inter-
bred to produce homozygous mice.
Immunostaining
For whole-mount staining, mouse 9.5-d embryos were killed. Samples
were pretreated by microwaving in PBS for 20 s and fixed in 4% PFA/PBS
for 30 min. They were dehydrated in methanol and bleached with 30%
H202. Samples were then rehydrated, blocked with PBS-MT (0.2% Triton
X-100 and 1% skimmed milk/PBS), and incubated overnight with rat anti–
PECAM-1 mAb followed HRP-conjugated goat anti–rat IgG (CHEMICON
International, Inc.). Next, they were washed with PBS-MT and PBS-T
(0.2% Triton X-100/PBS) each for 5 h. Bound antibodies were visualized
by incubating with 0.025% DAB, 0.08% NiCl2, and 30% H202 in PBS-T.
Immunofluorescence staining/peroxidase histochemistry for frozen and
paraffin sections, and ultra-thin section electron microscopy were per-
formed as previously described (Morita et al., 1999b).
Tracer experiments
Cld5
 /  intercross littermates were obtained by Caesarian section at em-
bryonic day 18.5 and resuscitated. The following solutions were perfused
from the left cardiac ventricle under a stereoscopic microscope using a
low-pressure perfusion apparatus (Terumo) within 1 min; 5  l/g body wt of
25 mg/ml microperoxidase (MP-11; 1,862 D; Sigma-Aldrich) in PBS con-
taining 1 mM CaCl2 (Knothe Tate et al., 1998); 1 ml/g body wt of 2 mg/ml
EZ-LinkTM Sulfo-NHS-Biotin (443 D; Pierce Chemical Co.) in PBS con-
taining 1 mM CaCl2 (Chen et al., 1997; Furuse et al., 2002); and 1 ml/g
body wt of 100  g/ml Hoecht stain (H33258; 562 D; Calbiochem-Nova-
biochem) in PBS containing 1 mM CaCl2 with or without 1 mg/ml tet-
ramethylrhodamine-conjugated lysine-fixable dextran (10 kD; Molecular
Probes; Chang-Ling et al., 1992; Hu et al., 2000). 1–5 min after perfusion,
the whole brain was removed, fixed with 3.7% formaldehyde, and frozen
using liquid nitrogen. In the frozen sections, the distribution of microper-
oxidase, EZ-LinkTM Sulfo-NHS-Biotin, Hoecht stain, and dextran were ex-
amined as described previously (Chang-Ling et al., 1992; Chen et al.,
1997; Knothe Tate et al., 1998; Hu et al., 2000; Furuse et al., 2002).
MRI
Mouse 18.5-d embryos were resuscitated and anesthetized with pentobar-
bital (50  g/g body wt), and Gd-DTPA solution ( 7  l in total) was in-
jected transcardially. The mice were placed in the head-up position on a
polystyrene sledge, the position of the head was fixed with adhesive tape,
and the sledge temperature was maintained at 34   1 C using a warm air
flow. 
1H magnetic resonance images were obtained using an NMR spec-
trometer (7.05 T; model AMX-300wb; Bruker) with an active shielded gra-
dient (micro2.5) and an 
1H birdcage resonator (15-mm diam). The T1-
weighted sagittal gradient-echo imaging (repeat time [TR]   100 ms,
echo-time [TE]   4.4 ms, flip angle   45 ) was obtained with 78  m in-
plane resolution and 0.75-mm slice thickness. The T1 relaxation times
were measured using an inversion recovery fast-imaging sequence (Haase
et al., 1989) with a series of 16 detection pulses (12  flip angle), 10 inver-
sion recovery delays (40–7,030 ms), 156- m in-plane resolution, 0.75-mm
slice thickness, 3,000-ms TR, 2.4-ms TE, and 2 accumulations. On the as-
sumption of a two-compartment model with water exchange between Gd-
DTPA–accessible space and nonaccessible space (Fabry and Eisenstadt,
1978; Schwarzbauer et al., 1997), the slow relaxation rate (RS) given by
RS   0.5 ((Rg   Rn   kn/f)   {[Rg   Rn   kn(1   2f)/f]
2   4kn
2(1   f)/f}
0.5),
where Rn is the intrinsic 1/T1 of water in the brain, kn is the rate constant ofT
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diffusive water influx from the Gd-DTPA–nonaccessible space into the ac-
cessible space, f and Rg are the volume fractions of water, and 1/T1 for wa-
ter in the Gd-DTPA–accessible space, respectively. The Rg was estimated
from the relaxivity of Gd-DTPA (Caravan et al., 1999), the dosage of the
Gd-DTPA and the volume fraction of extracellular fluid.
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